CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
SAGE Therapeutics Inc Company Snapshot
SAGE Therapeutics Inc operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares SAGE Therapeutics Inc with three other companies in this sector in the United States: Recro Pharma Inc (2018 sales of $77.35 million of which 100% was CDMO), Radius Health Inc ($99.24 million of which 100% was Drug Manufacturer), and MorphoSys AG ($90.07 million of which 70% was Proprietary Development).

Sales Analysis.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
SAGE Therapeutics Inc
  Stock Performance Chart for SAGE Therapeutics Inc
 
  Stock Data: Recent Stock Performance:
  Current Price (11/8/2019): 146.40
(Figures in U.S. Dollars)
1 Week 1.7%   13 Weeks 4.2%  
4 Weeks -13.5%   52 Weeks 11.8%  
 
SAGE Therapeutics Inc Key Data:
  Ticker: SAGE Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2018 Sales 90,273,000
(Year Ending Jan 2019).
Employees: 637
  Currency: U.S. Dollars Market Cap: 7,562,583,775
  Fiscal Yr Ends: December Shares Outstanding: 51,656,993
  Share Type: Common Closely Held Shares: 1,246,068
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.